H1 Revenues of $7.6 million and Controlled Net Loss
Results Release and Webinar Discussion on Morning of May 14, 2026
MISSISSAUGA, ON / ACCESS Newswire / April 27, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that one of its clients...
Releasing Episodes of Season Two of "Diagnostics: Beyond the Lab" Podcast
MISSISSAUGA, ON / ACCESS Newswire / April 16, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and...
Presenting Results of Novel Product for Quality Control of RNA-based Assays
MISSISSAUGA, ON / ACCESS Newswire / March 26, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQB:MBXBF) ("Microbix®" or the Company"), a life sciences innovator, manufacturer, and exporter, announces the...
QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays
Drug Substance Manufacturing Methods Modernized
Using Shareholder-Approved Plan to Incentivize and Retain